These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3951348)

  • 21. Adaptive response in patients treated with 131I.
    Monsieurs MA; Thierens HM; Vral AM; Van De Wiele C; De Ridder LI; Dierckx RA
    J Nucl Med; 2000 Jan; 41(1):17-22. PubMed ID: 10647600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The frequency and spectrum of cytogenetic anomalies in employees of Siberian Group of Chemical Enterprises].
    Litviakov NV; Freĭdin MB; Haliuzova MV; Sazonov AJ; Vasil'eva EO; Al'bakh EN; Isubakova DS; Blinov AP; Rodionova VI; Kut'ko AA; Karpov AB; Takhauov RM
    Radiats Biol Radioecol; 2014; 54(3):283-96. PubMed ID: 25764832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic efficacy of iodine 131 in autonomous thyroid adenomas--59 cases].
    Guermazi F; Fekih MA; Kraiem A; Mtimet S
    Tunis Med; 1991 Dec; 69(12):705-9. PubMed ID: 1808784
    [No Abstract]   [Full Text] [Related]  

  • 24. Thyroid uptake and imaging with iodine-123 at 4-5 hours: replacement of the 24-hour iodine-131 standard.
    Floyd JL; Rosen PR; Borchert RD; Jackson DE; Weiland FL
    J Nucl Med; 1985 Aug; 26(8):884-7. PubMed ID: 3839845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical value of fine-needle aspiration biopsy of the thyroid gland].
    Filatov AA; Vetshev PS; Sviatov AV; Chilingaridi KE; Ippolitov IKh; Ufimtseva AG; Opalenova VA; Shatikhin AI
    Khirurgiia (Mosk); 1991 Oct; (10):81-6. PubMed ID: 1803100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative diagnostic effectiveness of different radionuclide methods in patients with nodular goiter].
    Pham VZ; Nguyen TK
    Med Radiol (Mosk); 1984 Jul; 29(7):56-9. PubMed ID: 6748890
    [No Abstract]   [Full Text] [Related]  

  • 28. Micronucleus yield and colorimetric test as indicators of damage in patients' lymphocytes after 131I therapy.
    Catena C; Conti D; Trenta G; Righi E; Breuer F; Melacrinis FF; Montesano T; Ventroni G; Ronga G
    J Nucl Med; 2000 Sep; 41(9):1522-4. PubMed ID: 10994733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of the definitive treatment of autonomy in iodine deficiency goiter].
    Emrich D; Reinhardt M
    Nuklearmedizin; 1989 Feb; 28(1):11-6. PubMed ID: 2710642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of technetium-99m and iodine-123 nodules: correlation with pathologic findings.
    Beierwaltes WH
    J Nucl Med; 1990 Apr; 31(4):400-2. PubMed ID: 2157830
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of a custom-made lead collar on dose rates of patients treated with 131I.
    Stapel AG; van der Zant FM; Gommans GM; Boer RO; Reigman HI
    Health Phys; 2009 May; 96(5 Suppl 2):S64-8. PubMed ID: 19359844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nontoxic nodular goiter (adenomatous goiter).
    Sedgwick CE
    Major Probl Clin Surg; 1974; 15(0):121-5. PubMed ID: 4423281
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum thyroglobulin level in patients with diffuse and nodular goiter, after therapeutic application of stable iodine.
    Djurica SN; Cirović M; Tasovac-Ponomarev D
    Exp Clin Endocrinol; 1992; 99(1):21-5. PubMed ID: 1628693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation dose to patients and relatives incident to 131I therapy.
    Zanzonico PB
    Thyroid; 1997 Apr; 7(2):199-204. PubMed ID: 9133684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 131I therapy of toxic and non-toxic goiters.
    Beckers C
    Q J Nucl Med; 1999 Dec; 43(4):291-6. PubMed ID: 10731779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs.
    Esfahani AF; Kakhki VR; Fallahi B; Eftekhari M; Beiki D; Saghari M; Takavar A
    Hell J Nucl Med; 2005; 8(3):158-61. PubMed ID: 16390021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chromosome anomalies of lymphocytes due to thyroid gland studies using 131-I].
    Zsebök ZB; Sellyei M; Baumgartner E
    Strahlentherapie Sonderb; 1972; 72():253-5. PubMed ID: 4659338
    [No Abstract]   [Full Text] [Related]  

  • 38. Scintigraphic demonstration of sequestered nodular goiter. A lateral aberrant thyroid rest.
    Liu RS; Yen TC; Yeh SH; Lee CH
    Clin Nucl Med; 1992 May; 17(5):402-3. PubMed ID: 1587049
    [No Abstract]   [Full Text] [Related]  

  • 39. The significance of chromosomal aberrations in indium-111-labeled lymphocytes.
    Thakur ML; McAfee JG
    J Nucl Med; 1984 Aug; 25(8):922-7. PubMed ID: 6431062
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of small amounts of 131I on 99mTc detection by the scintillation camera.
    Makler PT; Eymontt MJ; Bloch P; Koch K
    J Nucl Med; 1976 Dec; 17(12):1100-1. PubMed ID: 993844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.